PoC (ポイントオブケア) 診断薬の世界市場：将来展望
Global Point-of-Care Diagnostics Market 2019-2025
|発行||Orion Market Research Pvt Ltd||商品コード||869644|
|PoC (ポイントオブケア) 診断薬の世界市場：将来展望 Global Point-of-Care Diagnostics Market 2019-2025|
|出版日: 2019年06月10日||ページ情報: 英文||
当レポートでは、世界のPoC (ポイントオブケア) 診断の市場の現状と見通しについて分析し、システムの概要や市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、世界全体および地域別の市場動向の見通し (今後7年間分)、セグメント別 (用途別、処方形態別、エンドユーザー別) の詳細動向、最新の市場競争状況、主要企業のプロファイルなどを調査しております。
Global Point-of-Care Diagnostics Market Size, Share & Trends Analysis Report by Application (Cardiology, Diabetes, Infectious Diseases, Oncology and Other Applications), by Prescription Mode (Over-The-Counter Testing and Prescription-Based Diagnostics), by End-User (Hospital and Clinics, Home Care, and Other), and Forecast, 2019-2025
The point-of-care diagnostics are medical devices used for early diagnosis & monitoring of various diseases such as cancer, diabetes, infectious diseases, and others. There is a high growth opportunity in this market due to the increase in investment by public foundations and new products development. However, the high cost of the device and its installation along with product recall due to technical failure are some of the restraint to the point-of-care diagnostics market.
The global point-of-care diagnostics market is segmented on the basis of application, prescription mode and end user. On the basis of the application, it is further classified into cardiology, diabetes, infectious diseases, oncology and other applications. The infectious disease segment is expected to show a significant growth owing to the increase in the number of affected patients and increasing awareness about infectious disease testing point-of-care devices. On the basis of the prescription mode, the market is classified into the over-the-counter testing and prescription-based diagnostics. Among these, the prescription-based diagnostics segment are expected to show significant growth attributed to lack of awareness on over-the-counter testing devices.
The global point-of-care diagnostics market is further analyzed and segmented on the basis of regions into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to have considerable market in terms of market share in the global point-of-care diagnostics market. This is mainly attributed to the high prevalence of diseases, development of healthcare infrastructure and mostly due to the presence of major players such as Abbott Laboratories and Danaher Corp. Asia-Pacific is growing due to increasing quality of the healthcare system and increasing awareness among people in emerging countries, such as India, are the reason for the high market growth.
Key market players operating in the global point-of-care diagnostics market include F. Hoffmann-La Roche Ltd., Danaher Corp., Abbott Laboratories, Inc., bioMerieux SA, and Siemens Healthcare GmbH among others. These companies adopt various strategies such as partnership & collaborations, finding a new market or Product innovations in their core competency in order to stay competitive in the market. For instance, In April 2017, Chembio Diagnostics, Inc., collaborated with FIND to develop Hepatitis-C virus detecting point-of-care device.
The market study of the global point-of-care diagnostics market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behaviour and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
5.1.4 Infectious Diseases
5.1.5 Other Applications (Haematology Testing, Pregnancy Testing)